- Home
- MYGN vs OFG Comparison
MYGN vs OFG Comparison
Compare MYGN & OFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MYGN | OFG |
|---|---|---|
| Founded | 1991 | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.6M | 1.6B |
| IPO Year | 1996 | 2012 |
Fundamental Metrics
Financial Performance| Metric | MYGN | OFG |
|---|---|---|
| Price | $4.33 | $39.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | $7.64 | ★ $43.40 |
| AVG Volume (30 Days) | ★ 1.7M | 278.1K |
| Earning Date | 05-05-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 3.51% |
| EPS Growth | N/A | ★ 8.27 |
| EPS | N/A | ★ 4.58 |
| Revenue | ★ $771,400,000.00 | N/A |
| Revenue This Year | $6.89 | $10.14 |
| Revenue Next Year | $5.35 | $1.38 |
| P/E Ratio | ★ N/A | $8.70 |
| Revenue Growth | ★ 2.33 | N/A |
| 52 Week Low | $3.76 | $33.15 |
| 52 Week High | $8.63 | $46.11 |
Technical Indicators
Market Signals| Indicator | MYGN | OFG |
|---|---|---|
| Relative Strength Index (RSI) | 37.15 | 49.50 |
| Support Level | $4.24 | $37.93 |
| Resistance Level | $5.69 | $40.73 |
| Average True Range (ATR) | 0.31 | 0.85 |
| MACD | -0.03 | 0.17 |
| Stochastic Oscillator | 12.15 | 70.95 |
Price Performance
Historical ComparisonAbout MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
About OFG OFG Bancorp
OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.